LATS1/2-deficient melanomas secreted nucleic-acid-rich extracellular vesicles (EVs) that stimulated the host TLR-MYD88/TRIF-IFN nucleic-acid-sensing pathways, inducing anti-tumor inflammatory reactions. Here, LATS1 is linked to melanoma.